(Press-News.org) MIAMI--The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study being presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April 24-27. The U.S. regimen was associated with more acute toxicity to the kidneys and liver.
This and other research informed the recent decision of the Children's Oncology Group (COG) to switch to the busulfan-based regimen used for years in Europe and Egypt, said senior author Leslie E. Lehmann, MD, clinical director of pediatric stem cell transplantation at the Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) in Boston.
Both approaches to high-risk neuroblastoma employ high doses of chemotherapy to eradicate cancer cells followed by infusion of the patient's previously collected stem cells to allow the patient to recover more quickly and safely. Since 2007, physicians at DF/CHCC and others in the Children's Oncology Group had been using a combination of high-dose carboplatin, etoposide, and melphalan to prepare patients for transplant, said Lehmann.
European centers have preferred busulfan and melphalan over the platinum-based regimen.
"We have had a long-standing collaboration with Children's Cancer Hospital Egypt in Cairo, which is under the leadership of senior author Dr. Alaa Elhaddad," Lehmann said.
"We decided to compare the toxicities in patients who received care that was very similar except for the drugs used in the preparative regimen.
"We found there was no difference in survival, but our regimen was associated with more liver and kidney toxicity and more bloodstream infections," she noted. "This was very useful information as COG contemplated switching to the European approach."
In addition to the idea of using toxicity data to choose between approaches of similar efficacy, Lehmann noted, "This study demonstrates you can have true collaboration between transplant centers located in very different parts of the world."
INFORMATION:
First author of the study is Yasser Elborai, MD, of the Children's Cancer Hospital Egypt.
DF/CHCC used no outside funding for its research for this study.
Written by Richard Saltus, Dana-Farber/Children's Hospital Cancer Center.
Dana-Farber/Children's Hospital Cancer Center
Since 1947, Boston Children's Hospital and Dana-Farber Cancer Institute have provided comprehensive care for children and adolescents with cancer through Dana-Farber/Children's Hospital Cancer Center. The two Harvard Medical School affiliates share a clinical staff that delivers inpatient care at Boston Children's and outpatient therapies at Dana-Farber's Jimmy Fund Clinic. The Boston Children's inpatient pediatric cancer service has 33 beds, including 13 designated for stem cell transplant patients.
Boston Children's is also the site of DF/CHCC inpatient clinical translational research in pediatric malignancies and has long supported the operation of an effective and productive stem cell transplant service. It has a long history of investment in and support of both clinical and basic cancer research, with more than $7.3 million in National Cancer Institute research support and 47,000 square feet of space devoted to cancer research. It is a recognized center of excellence in angiogenesis, cellular/molecular immunology, cancer genetics, and molecular signaling research.
Toxicity differences inform decision on conditioning for neuroblastoma transplants
2013-04-25
ELSE PRESS RELEASES FROM THIS DATE:
Chernobyl follow-up study finds high survival rate among young thyroid cancer patients
2013-04-25
Chevy Chase, MD—More than a quarter of a century after the Chernobyl nuclear disaster, many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Following the April 26, 1986 explosion and fire at the Chernobyl nuclear plant in the former Soviet Union, the number of children and teenagers diagnosed with differentiated thyroid cancer spiked in Ukraine, Belarus and western areas of Russia. ...
Discovery of wound-healing genes in flies could mitigate human skin ailments
2013-04-25
Biologists at UC San Diego have identified eight genes never before suspected to play a role in wound healing that are called into action near the areas where wounds occur.
Their discovery, detailed this week in the open-access journal PLOS ONE, was made in the laboratory fruit fly Drosophila. But the biologists say many of the same genes that regulate biological processes in the hard exoskeleton, or cuticle, of Drosophila also control processes in human skin. That makes them attractive candidates for new kinds of wound-healing drugs or other compounds that could be used ...
Study shows drinking one 12oz sugar-sweetened soft drink a day can increase the risk of type 2 diabetes by 22 percent
2013-04-25
Drinking one (or one extra)* 12oz serving size of sugar-sweetened soft drink a day can be enough to increase the risk of developing type 2 diabetes by 22%, a new study suggests. The research is published in
Diabetologia (the journal of the European Association for the Study of Diabetes) and comes from data in the InterAct consortium**. The research is by Dr Dora Romaguera, Dr Petra Wark and Dr Teresa Norat, Imperial College London, UK, and colleagues.
Since most research in this area has been conducted in North American populations, the authors wanted to establish if ...
Using microbubbles to improve cancer therapy
2013-04-25
Microbubbles decrease the time and acoustic power of ultrasound required to heat and destroy an embedded target, finds research in BioMed Central's open access journal Journal of Therapeutic Ultrasound. If these results can be replicated in the clinic, microbubbles could improve the efficiency of high intensity ultrasound treatment of solid tumors.
High intensity ultrasound is already used to treat solid tumors. Ultrasound can be focused through soft tissue and, because it does not require probes or surgery, is non-invasive. However if the tumor is behind the ribcage ...
Precision agriculture improves farming efficiency, has important implications on food security
2013-04-25
Precision agriculture promises to make farming more efficient and should have an important impact on the serious issue of food security, according to a new study published in Significance, the magazine of the Royal Statistical Society and the American Statistical Association. In an article about the study in the magazine's May issue, University of Reading Professor Margaret A. Oliver, BSc, PhD, assesses how there is potential to manage land more effectively to improve the farming economy and crop quality, and to ensure food security.
Spatial variation is at the core of ...
Researchers make a significant step forward in combating antibiotic resistance
2013-04-25
Antibiotic resistance is a global problem. The World Health Organisation (WHO) estimates that for tuberculosis alone multi-drug resistance accounts for more than 150,000 deaths each year. WHO warns of "a doomsday scenario of a world without antibiotics," in which antibiotic resistance will turn common infections into incurable killers and make routine surgeries a high-risk gamble.
Certain types of bacteria are a scourge of the hospital environment because they are extremely resistant to antibiotics and consequently difficult, if not impossible, to treat. This group of ...
Mysterious hot spots observed in a cool red supergiant
2013-04-25
Astronomers have released a new image of the outer atmosphere of Betelgeuse – one of the nearest red supergiants to Earth – revealing the detailed structure of the matter being thrown off the star.
The new image, taken by the e-MERLIN radio telescope array operated from the Jodrell Bank Observatory in Cheshire, also shows regions of surprisingly hot gas in the star's outer atmosphere and a cooler arc of gas weighing almost as much as the Earth.
Betelgeuse is easily visible to the unaided eye as the bright, red star on the shoulder of Orion the Hunter. The star itself ...
Ancient Earth crust stored in deep mantle
2013-04-25
Washington, D.C.— Scientists have long believed that lava erupted from certain oceanic volcanoes contains materials from the early Earth's crust. But decisive evidence for this phenomenon has proven elusive. New research from a team including Carnegie's Erik Hauri demonstrates that oceanic volcanic rocks contain samples of recycled crust dating back to the Archean era 2.5 billion years ago. Their work is published in Nature.
Oceanic crust sinks into the Earth's mantle at so-called subduction zones, where two plates come together. Much of what happens to the crust during ...
Psychopaths are not neurally equipped to have concern for others
2013-04-25
Prisoners who are psychopaths lack the basic neurophysiological "hardwiring" that enables them to care for others, according to a new study by neuroscientists at the University of Chicago and the University of New Mexico.
"A marked lack of empathy is a hallmark characteristic of individuals with psychopathy," said the lead author of the study, Jean Decety, the Irving B. Harris Professor in Psychology and Psychiatry at UChicago. Psychopathy affects approximately 1 percent of the United States general population and 20 percent to 30 percent of the male and female U.S. prison ...
Researchers use nasal lining to breach blood/brain barrier
2013-04-25
BOSTON (April 24, 2013) – Neurodegenerative and central nervous system (CNS) diseases represent a major public health issue affecting at least 20 million children and adults in the United States alone. Multiple drugs exist to treat and potentially cure these debilitating diseases, but 98 percent of all potential pharmaceutical agents are prevented from reaching the CNS directly due to the blood-brain barrier.
Using mucosa, or the lining of the nose, researchers in the department of Otology and Laryngology at the Massachusetts Eye and Ear/Harvard Medical School and the ...